Los Altos Hills, CA, United States of America

John Brian Mumm

This inventor holds 13 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: Armo Biosciences, Inc., Merck Sharp + Dohme Corp., Eli Lilly and Company. Active years: 2014-2023.

USPTO Granted Patents = 13 (Patent Applications = 8)

% Patents Active = 92.3

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 18(Granted Patents)

Company Filing History:

8 out of 13

Armo Biosciences, Inc.

patents

4 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 4,508

Eli Lilly and Company

patents

Years Active: 2014-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11814679 - Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same (2023-11-14),

2. 11413332 - Methods of using interleukin-10 for treating diseases and disorders (2022-08-16),

3. 10618970 - Method of treating cancer with IL-10 and antibodies that induce ADCC (2020-04-14),

4. 10568968 - Methods for treatment of cancer with therapeutic combinations comprising PEG-IL-10 (2020-02-25),

5. 10398761 - Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers (2019-09-03),

6. 10293043 - Methods of lowering serum cholesterol (2019-05-21),

7. 10209261 - Method for assessing protein identity and stability (2019-02-19),

8. 10195274 - Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10 (2019-02-05),

9. 10010588 - Methods of using pegylated interleukin-10 for treating hyperlipidemia (2018-07-03),

10. 9833514 - Use of pegylated IL-10 to treat cancer (2017-12-05),

11. 9823255 - Method for assessing protein identity and stability (2017-11-21),

12. 9364517 - Method of treatment of lymphoma with pegylated IL-10 (2016-06-14),

13. 8865652 - Method of treating solid cancers with pegylated IL-10 (2014-10-21),

Title: John Brian Mumm: Innovator in Immunology

Introduction

John Brian Mumm is a prominent inventor based in Los Altos Hills, California. He has made significant contributions to the field of immunology, particularly in the development of therapeutic methods for treating diseases. With a total of 13 patents to his name, Mumm's work has the potential to impact the treatment of various immune-related disorders.

Latest Patents

Mumm's latest patents include groundbreaking methods for the production of antigen-specific CD8+ T cells. These methods involve isolating CD8+ T cells that express a disease antigen-specific T cell receptor. The patents also cover therapeutic methods for administering these isolated CD8+ T cells to subjects, as well as genetically modifying them to express disease antigen-specific T cell receptors or chimeric antigen receptors. Additionally, he has developed methods for using interleukin-10 to treat diseases, including cancer and inflammatory disorders, by combining it with other agents.

Career Highlights

Throughout his career, John Brian Mumm has worked with notable companies such as Armo Biosciences, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the medical field.

Collaborations

Mumm has collaborated with esteemed colleagues, including Martin Oft and Ivan Ho Chan. These partnerships have further enriched his research and development efforts in immunology.

Conclusion

John Brian Mumm is a distinguished inventor whose work in immunology has led to significant advancements in therapeutic methods for treating diseases. His contributions continue to shape the future of medical treatments and improve patient outcomes.